Skip to main content.

Martha Rosenberg's blog posts

posted 08/13/2015

Many are baffled why the suicide rate in the United States is rising despite antidepressant use being at an all time high. Suicide has risen to 38,000 a year, says USA Today, after falling in the 1990s.

posted 07/24/2015

It is no secret that the pill profit party is over for drug companies. Bestselling pills like Lipitor, Seroquel, Zyprexa, Singular, Concerta, Cymbalta and Abilify have gone off patent and Wall Street is moving on to industries that offer better returns.

posted 06/30/2015

Milk is rarely seen as a health food. Why is it marketed to children when other sources of calcium exist?

posted 06/11/2015

Public Citizen is charging that the FDA inappropriately expanded the approved use of Vanda's drug, Hetlioz, for the disorder beyond its original indication for use in blind people.

posted 06/03/2015

It's been five years since excitement over a female or "Pink Viagra" faded when the FDA nixed the drug candidate. Now flibanserin is back before an FDA committee that could recommend approval.

posted 05/30/2015

More than two thirds of U.S. adults are now overweight and it is fair to say that almost all of them overeat. It is not too difficult to overeat when food and snack ads are everywhere--as are the products themselves

posted 05/22/2015

The New England Journal of Medicine has published a report suggesting that the rate of severe mental illness among children and adolescents has dropped substantially in the past generation — not risen.

posted 05/11/2015

Direct-to-consumer advertising (DTC) has been accused of "selling" depression and over-treating or medicalizing lifestyle problems that probably don't need drugs. Yet a quick look at old issues Journal of the American Medical Association (JAMA) shows that the tactics are far from new.

posted 04/27/2015

This week a New York Times article revealed why Michael Botticelli, the director of the White House Office of National Drug Control Policy, is becoming so successful in his post. He is recovering from addiction himself and “the first person in substance-abuse recovery to hold the position."

posted 04/20/2015

So many men today believe they suffer from "low T" and pursue testosterone therapy. But is it marketing or medicine? I caught up with an expert to ask him why testosterone seems to be of such interest particularly to men and whether men should be concerned or cautious.

Martha Rosenberg's Blog

Much direct-to-consumer drug advertising makes a mockery of the entire U.S. health care system by... more »
posted 03/15/18
Review: Mental Health, Inc. exposes how various entities - from indifferent professional... more »
posted 01/06/18
Gary Younge, a black reporter who grew up in England demonstrates in a moving new book, asks hard... more »
posted 06/10/17

Martha Rosenberg's Latest Comments

Posted by Martha Rosenberg | Saturday, 2016-03-12, 12:02
Anxiety and alcoholism are not "mental illnes." Whenever they are termed that way and there is...
Posted by Martha Rosenberg | Wednesday, 2015-09-30, 06:57
Like the removal of pink slime from school lunch programs and rBGH from almost all milk, consumer...
Posted by Martha Rosenberg | Friday, 2015-08-14, 10:31
When reporters expose drug company marketing that pretends to be grassroots, patients often write...

Martha Rosenberg's Work

According to whistleblowers who sold Xolair at Novartis and Genentech--a scheme of kickbacks and bribes, misinformation about Xolair’s approved uses and risks and insurance fraud was used to sell Xolair

After an 18 month investigation into the high cost of Gilead’s hepatitis C drug Sovaldi, the Senate Finance Committee said the prices did not reflect the cost of research and development and that Gilead cared about “revenue” not “affordability and accessibility.”

Drug companies have "bought" opioid favorable guidelines and the FDA continues to approve new opioids. Don't blame patients for the opioid abuse epidemic